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Background: Non communicable chronic diseases (including respiratory ones) are the leading cause of death
and disability. To cope with them we need to redesign the health system, improving primary prevention, screening,
and outpatient services, while fully integrating different branches of the health service. The Italian Ministry of Health
published extended guidelines on integrated COPD management (COPD-GL) in 2010. In2011 a condensed version
was produced. These documents define appropriateness of management regarding both the specialist and the
health service.
Methods: An internal audit on how clinical practice conforms to COPD-GL standards was implemented in one Italian
region involving 29 respiratory units (RU) (65.8% of the total regional RU): data were collected from the clinical database
at time zero and after 6 months. In the meantime, specialists of RU underwent education on COPD-GL.
Results: At time zero, significant gaps between current practice and recommendations emerged both in medical
practice (mean agreement 25%) and in the health organization (48%). At month 6 the gaps were reduced more in
clinical practice (60.7%) than in organization (54.7%).
Conclusions: It is easier to resolve the gaps in specialist clinical practice than the organizational gaps, changing
which is the politicians’ task. Correcting specialists’ inappropriateness may be worthless if this is not accompanied by
improvement of the organizational obstacles. The search for appropriateness should not be limited only to specialists
or to a strict control of drug prescription but should include all the organizational aspects. Implementation of COPD-GL
calls for actions on the part of both specialists and the health system.
Keywords: Appropriateness, Assistance, Health organization, Specialized pulmonology practiceBackground
In September 2011 the United Nations (UN) stated that
chronic non-communicable diseases (NCD) constitute a
global emergency, in that they cause more deaths than
all other causes combined [1]. Of the four considered to
be the most important NCDs epidemiologically and eco-
nomically speaking, one is chronic obstructive pulmo-
nary disease (COPD) [2]. The official UN declaration as
well as previous official documents of the World Health
Organization (WHO) emphasized the importance of
chronic lung diseases to such a point that in 2005 the
Global Alliance against Respiratory Diseases (GARD) was* Correspondence: snardini@qubisoft.it
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unless otherwise stated.set up by WHO, and officially launched in 2006 [3].
GARD, working through General Assemblies, has pro-
duced official recommendations and practical material for
their implementation [4]. Also the European Respiratory
Society (ERS) has produced a strategy document for the
control of chronic respiratory diseases [5,6] which was pre-
sented on 6th September 2011 at the European Parliament
and, at the 2011 ERS Annual Congress. The Italian
government, for its part, is a member of GARD Inter-
national and has set up a national GARD [7] organization,
aimed at building a network to improve the health care for
chronic respiratory diseases.
All stakeholders involved agree on the need to modify
the current model of health care for chronic disease
management. The core of the new model must be pre-
vention, both primary (universal and individualized) andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Nardini et al. Multidisciplinary Respiratory Medicine 2014, 9:40 Page 2 of 12
http://www.mrmjournal.com/content/9/1/40secondary (early diagnosis), but not less important is the
need to optimize the management of those already af-
fected by the disease through continuity of treatment
achieved by means of patient self-management, rehabili-
tation and the underlying supports required for palliative
care [8].
AIMAR, which adhered to GARD when it was first set
up in 2006, has tackled the issue of chronic respiratory
diseases both from the perspective of education of
specialists and general practitioners (GPs) and from the
research point of view, setting up projects aimed at
investigating specific aspects, such as for example the
problem of underdiagnosis and the possibility of early
diagnosis of obstructive respiratory disease through the
project “SOS-Respiro” (SOS-Breath) [9].
The Italian National Health System is undergoing a
period of profound restructuring in order to adapt to the
changed epidemiological situation despite the severe
restrictions imposed by the reduced availability of
resources. For this reason, the challenge - more pressing
in some regions of Italy than in others - is to achieve the
changes envisaged by the national and international go-
vernmental organizations at an overall cost outlay that is
lower than the current budget or, at least, that inverts
the current trend for increase seen up till now.
In 2010 AGE.NA.S (National Agency for Regional
Health Services) published the Italian guidelines for the
management of COPD [10]. In the same year a joint-
society Commission formed by the three major Scientific
Societies operating in the field of respiratory medicine in
Italy began producing – in conjunction with a scientific
society of General Medicine – a document to translate
these guidelines into practice, creating a “light”, prac-
tical, “user-friendly” product by means of schemes and
flow diagrams. This document was published in 2011
[11], and was officially presented to the Senate of the
Republic the same year and an updated version followed
in 2013 [12]. Immediately following the production of
these documents, the need was felt to verify if and to
what extent their implementation was possible in clinical
practice and, if difficulties were found, the reasons for
these problems.
AIMAR, which took part with its representatives in the
drafting of both the above documents, launched back in
2011 the editorial project ALT-BPCO “Appropriateness of
Long Term treatment of COPD” which had as its objective
to verify the applicability of the guidelines and evidence
eventual obstacles for their implementation. ALT-BPCO
(STOP-COPD in English) was launched as a pilot project
in one Italian region with the aim to provide health profes-
sionals with the up-to-date elements to reflect on their
own diagnostic and therapeutic habits and help them guide
and manage the organizational changes.
This article reports the results of the above audit project.Methods
The audit consisted in comparing the clinical reality
with a defined standard in order to identify significant
gaps and propose consequent actions for improvement.
In an Italian region, Campania, a group of specialists from
29 Pulmonology Units, representing about two-thirds
(65.8%) of the Pulmonology Units present in the region,
agreed to take part in the project scheduled to be carried
out in 2012. Their role was to compare the data contained
in their own outpatient records regarding patients affected
with COPD (“the clinical reality”) with the current recom-
mendations (“the standard”). The study design consisted
in a preliminary set-up phase, a first investigative phase
followed by a meeting to discuss findings (in which all
Centers were involved) and a second phase of survey and
verification, then a final meeting to compare findings,
verify what gaps existed and present the study results.
In the preliminary phase, the scientific committee
established the instruments for the survey, i.e. the data
collection forms. It took as the starting point the recom-
mendations of the guidelines and joint-society document
[10,11] in the field of prevention, early diagnosis and
care. Three different forms were created. First, an Audit
form, which was used to record the clinical and func-
tional data extracted from the outpatient records of pa-
tients (50 per Pulmonology Unit) diagnosed with COPD,
in order to evaluate their conformity with what is estab-
lished by the diagnostic and treatment standards. These
audit forms were in the possession of each Pulmonology
Unit. A second form, a Summary Outline of the audit
forms, was used to summarize the results of the 50 audit
forms in a single report, completely anonymous, which
was sent to the Scientific Society. A third form, also sent
to the Scientific Society, the Implementation form, con-
tained the responses of individual specialists to questions
aimed at verifying the effective availability at organizational
level (e.g. setting up of the network) of what the guidelines
recommend.
In a first plenary session held in February 2012 the data
collection forms were shared, analyzed and discussed with
all participants.
Concerning the Audit form, the standard on which it
was based (“benchmark”) were the recommendations of
the AGE.NA.S. guidelines [10] in relation to the appro-
priate diagnostic classification and staging and the Joint
society document [11] for the successive follow up of
the COPD patient. The Patient form thus contained all
the parameters recommended in these documents, as
reported in Table 1 (alongside each parameter is
reported the reference to one of the two documents and
relative page number).
Concerning the Implementation form, the study re-
quested participants to report the data indicated in
Table 2. Also in this case, the standards (“benchmarks”)
Table 1 Parameters included in the Audit form (for an
explanation, see text [10,11])
1 Spirometry performed less than 1 year previously ([10], pg. 38)
2 At least one global spirometry ([10], pg. 40)
3 Functional severity stage ([10], pg. 44)
4 Body mass index (BMI) ([10], pg. 46)
5 Comorbidities ([10], pg. 155-160)
6 Dyspnea ([10], pg. 46)
7 Type of scale used to assess Dyspnea ([10], pg. 46)
8 Walking test ([10], pg. 41)
9 Blood oxygen saturation ([10], pg. 40)
10 Arterial blood gases analysis ([10], pg. 40)
11 Smoking status ([10], pg. 54)
12 Pharmacological and behavioral smoking cessation treatment for
smoker patients ([10], pg. 195)
13 Number of exacerbations in the previous year ([11], pg. 26)
14 Number of exacerbations treated with antibiotic and systemic
steroids in the previous year ([11], pg. 26)
15 Treatment with oxygen therapy ([10], pg. 132)
16 Hospital admissions for COPD in the previous year ([10], pg. 131)
17 Admissions with use of mechanical ventilation ([10], pg. 133)
18 Second admission in less than three months from the previous
hospitalization
19 Prescribed long-term respiratory therapy ([10], pg. 58-80)
20 Prescribed drugs ([10], pg. 58-80)
21 Need for pulmonary rehabilitation ([10], pg. 168)
22 Setting of pulmonary rehabilitation
Table 2 Data to be recorded in the Implementation form
(for an explanation, see text [10,11])
1 Method of assessing the presence of bronchial obstruction
([10], pg. 38)
2 Organization of meetings with the reference GPs to exchange
information in the year preceding the survey
3 The possibility to administer, through the GPs in their area,
screening questionnaires for COPD ([10], pg. 44)
4 Knowledge about the risk cards for COPD of the National Health
Institute (NIH) ([10], pg. 43)
5 The possibility to use, with GPs of their area, the risk cards
6 The possibility to provide pharmacological and behavioral therapy
to COPD smoker patients ([10], pg. 57)
7 The modes of prescription of long-term oxygen therapy (LTOT) at
home ([10], pg. 84)
8 Periodic verification of the indication for and effective use of LTOT
([10], pg. 84)
9 The effective possibility to offer patients pulmonary rehabilitation
treatment ([10], pg. 178)
10 The availability of care facilities for COPD patients in the acute
phase ([10], pg. 87)
11 The possibility to educate patients as regards self-management
([10], pg. 178)
12 The possibility to jointly agree with the patient’s GP on discharge
of hospitalized COPD patients
13 The availability of specialist home care ([11], pg. 3-32)
14 The availability of tele-care facilities ([11], pg. 32)
Table 3 Scoring and evaluation of appropriateness in






< 20% Very inadequate
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ciety document [11]. Also in Table 2 alongside each para-
meter is reported the reference to one of the two
documents and relative page number. Some parameters
(e.g. n. 2, 5, 12) were included in that they were implicit
in the recommendation to form a “network” of health
professionals ([11], pg. 31 and following).
It was arbitrarily decided that, if the parameter recom-
mended by the guidelines as necessary to ensure appro-
priateness of the service was present in more than 80%
of the patient records examined (parameters reported in
the Audit forms and then transmitted in the Summary
forms), the correspondence and thus the clinical appro-
priateness was considered as excellent. For lower levels
of agreement, the parameters were ascribed a value arbi-
trarily based on the score, as shown in Table 3.
Concerning, on the other hand, appropriateness of
care at the organizational level (Implementation form) it
was decided that this was not possible if the elements
considered were absent, and thus the evaluation given
was established as adequate/inadequate based on whether
the score was, respectively, higher or lower than 80%.
This criterion may appear excessively “generous”, but theScientific Committee felt constrained to establish this
cutoff since to date standardized or valid criteria have
not existed for the management of COPD, which has
been seen as the responsibility of the specialist as an indi-
vidual rather than as part of a well-defined diagnostic-
therapeutic system.
In the following months (March-April 2012), data col-
lection was carried out, in each Center, followed by the
elaboration of the data transmitted to the Scientific Society
(first phase – first survey). In the month of May a meeting
of the study group was held to analyze and discuss these
results. Education on the guidelines was provided, which
covered the key difficulties in their implementation
evidenced by the first phase of data collection. Then,
in the month of October the data collection and successive
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comparison of the results between the two survey phases.
Results
Concerning the Audit forms (specialist practice), the
overall sample surveyed consisted of 1,450 patients. The
results of the analysis of the Audit forms are summa-
rized in Table 4. Concerning the Implementation form,
the study sample consisted of 29 centers. The findings of
the analysis of the Implementation forms are summa-
rized in Table 5. In Tables 4 and 5 the data compared,
obtained in the two phases of the project, are presented
graphically as follows: first phase/second phase.
Discussion
In Italy the current levels of care for people affected by
COPD consist of emergency or, in any case, non-
programmed hospital (outpatient or inpatient) interven-
tions for acute events (real or perceived as such by the
patient), but these interventions are not part of an
organic structure or follow up system organized accor-
ding to the principles of “managed care” or integrated
care [13,14], such as is already in practice elsewhere for
COPD with positive results [15].
It should be stressed that in any chronic disease,
and so in COPD too the goal to strive towards is an
“integrated” approach [8] based on the fundamentals of
self-management by the patient and caregiver through
simple instruments of control, lifestyle modification,
long-term treatment, and rehabilitation. For Pulmonology
the hallmarks are patient education about the disease (its
nature and course, as well as the signs and symptoms of its
worsening), smoking cessation, optimal bronchodilation
and exercise training. In the advanced stages, oxygen ther-
apy and home ventilation therapy come to play a funda-
mental role followed, in the terminal stages, by end-of-life
care. A recent document of the American Thoracic Society
[16] emphasizes that optimal treatment of COPD patients
calls for an individualized patient-centered approach that
addresses all aspects of the disease, manages the systemic
effects and comorbidities, and integrates the medical treat-
ment both inter-professionally (amongst the different
health professionals) and inter-sectorially.
Translating this into daily pulmonology clinical prac-
tice, the key concept on which integrated care hinges is
clearly appropriateness, i.e. an “appropriate” use of the
diagnostic tools, drugs, physical therapies and rehabilita-
tion procedures which should be made by the most
“appropriate” professional figure at a given stage of the
disease’s natural history, with an “appropriate” use of
economic resources.
To use the words contained in the Joint-society docu-
ment for the dissemination of the AGE.NA.S guidelines
[11]: “…the best management of the COPD patient isachieved through integration between the Pulmonologist,
GP and other specialists, involved each in turn as their
expertise is required; for each professional figure the tasks
to perform must be well defined, in the context of a com-
mon diagnostic and therapeutic path that is appropriate
for the different levels of disease severity.” And since it is
in the interests of both the patient and the general pub-
lic that COPD does not evolve towards stages of greater
severity or that this is delayed as long as possible, it is
necessary to eliminate “the main risk factors and install
a treatment that is pharmacological and non pharmaco-
logical, adequate and continuing in time, and diversified
according to the level of disease severity”.
The instruments for updating knowledge and integra-
tion are certainly the guidelines and the diagnostic-
therapeutic processes, in particular the latter because
they enable each professional figure to understand his/her
own place in the care pipeline and the relative figures of
reference further up or down the pipeline. But it is just as
important, given the need to know the patient’s situation
up-to-date (practically, in ‘real time’), to have logistic-
operational supports available for the routine networking
of information (in particular, patient medical charts de-
signed according to the guideline standards, so that infor-
mation contained in the GP’s records or in an online
patient medical file is instantly available to all involved),
the possibility of home specialist care, able to be activated
at any moment, and the availability of pulmonary rehabili-
tation. Without these supports, the realization of which is
beyond the capacity of the single health professional, it is
not possible to make any evaluation of appropriateness: an
appropriate therapy at the time of the exacerbation could
become excessive (and hence inappropriate) once the
acute event has passed. Oxygen therapy, indispensable at
the time of the exacerbation, could become superfluous
(and uselessly expensive) or even dangerous once the
patient has returned to the state prior to the acute event.
In pulmonology very often care continuity and access to
the latest information about the patient are lacking and so
the therapy continues without being updated (and thus is
at risk of being inappropriate), until the next exacerbation.
The aim of the editorial project ALT-BPCO was to
measure right from the outset how well individual health
professionals, their specialist wards, as well as the larger
operational context conform to the management recom-
mendations stemming from the AGE.NA.S guidelines
[10] and their updated disseminated version [11]
designed to facilitate their implementation. The data
collection forms made it possible to verify the adequacy
of the overall performance both of the specialist discipline
and of the organizational context in which it is inserted.
The strong and weak points of specialist activity, as well as
of the context, were “photographed” respectively through
the Summary and Implementation forms.
Table 4 Summary forms
First phase/
second phase
NUMBER OF CENTERS INVOLVED: 29/29
NUMBER OF PATIENTS ANALYZED IN EACH CENTER: 50/50
TOTAL PATIENTS ANALYZED: 1,450/1,450
NOTE: THE MEAN VALUES REPORTED BELOW REFER - UNLESS OTHERWISE INDICATED - TO THE PRESENCE OF THE PARAMETER EXPRESSED AS A PERCENTAGE OF THE
TOTAL (IN PRACTICE EACH CENTER TRANSMITTED THE PERCENTAGE OF THE TOTAL OF ITS 50 PATIENTS AND THE RESULT REPORTED HERE REPRESENTS THE SUM OF
THE PERCENTAGES OF ALL CENTERS).
Mean% of COPD patients with record of a spirometry
test performed less than 1 year ago
87,31/91,52
Mean% of patients reporting global spirometry 30,75/45,81
Mean% of patients with at least one global spirometry
reported
42,52/50,99
Mean% of patients with reported record of functional
severity staging
81,82/91,45
Mean n. of patients by level of severity (out of total
patients of the 29 centers.




8,31/10,12 15,86/16,1 12,05/15,01 8,32/9,24 5,96/0
Mean% of patients with reported BMI data 66,13/68,86
Mean% of patients with reported presence of
comorbidities
74,58/88,79
Mean% of patients with reported presence di
dyspnea
46,65/59,21
Scale used for the assessment of Dyspnea (NOTE:





VAS + BORG 6/2
MRC + VAS + BORG 3/3
MRC + VAS 1/1
MRC + BORG 3/7
NO RESPONSE 5/1
Total 29/29




















Table 4 Summary forms (Continued)
Mean% of patients with a SatO2 reported 74,62/90,41
Mean% of patients with a blood gases analysis reported 40,96/53,1
Mean% of patients with smoking status reported 75,20/85,1
Mean% of smoker patients treated with behavioral
smoking cessation therapy
9,79/14,1
Mean% of patients with report of eventual exacerbations
in the previous year
47,89/63,59
Mean n. of patients with n. exacerbations (out of total
patients of the 29 centers).
0 1 2 3 MORE THAN 3 NOT INDICATED
6,13/10,96 7,56/20,05 5,22/7,37 1,55/2,5 3,7/8,54 25,66/0
Mean% of patients with exacerbations treated with
antibiotic and systemic steroid
45,03/62,26
Mean% of patients on home oxygen therapy 25,24/36,59
Mean% of patients with hospital admissions for COPD
reported in the preceding year
28,67/44,9
Mean n. of patients with n. admissions (out of the total
patients of the 29 centers).
0 1 2 3 MORE THAN 3 NOT INDICATED
6,37/12,76 4,11/10,8 2,05/5,98 0,76/4,72 1,03/15,16 35,68/0
Mean% of patients with use of mechanical ventilation
reported
7,36/22,59
Mean% of patients with report of a second hospital
admission within a short delay (max 3 months) from
the first
7,62/9,48
Mean% of patients with long-term respiratory therapy
prescribed
80,93/85,93
Prescribed therapy (N. centers that indicated the specific
therapy; N.B. most Specialists/Centers indicated more
than one therapy)












10/11 11/21 14/20 18/20 20/25 13/17 20/29 13/12 14/17 3/11 1/0
Mean% of patients with need for pulmonary
rehabilitation (PR) recorded
23,10/25,55
Place where data sheet was carried out (n. centers per
place of identification):






















Table 4 Summary forms (Continued)
HOME 4/7
INPATIENT (IN NON-ACUTE WARD) 5/6





















Table 5 Implementation forms
METHOD USED BY THE CENTERS FOR ASSESSMENT OF BRONCHIAL OBSTRUCTION (First phase/second phase)
FIXED RATIO FEV1/FVC N^ 25 Centers (86,2%)/25 Centers (86,2%)
LOWER LIMIT OF NORMALITY (LLN) 4 Centers (13,8%)/4 Centers (13,8%)
CENTERS THAT HAD RECENTLY (<1 YEAR AGO) AT LEAST ONE EXCHANGE WITH GPs ON METHOD FOR CLASSIFYING RESPIRATORY SYMPTOMS
YES 23 Centers (79,3%)/25 Centers (86,21%)
NO 6 Centers (20,7%)/4 Centers (13,79%)
CENTERS THAT RETAIN THE APPLICATION POSSIBLE, THROUGH THEIR LOCAL GPs, OF A SCREENING QUESTIONNAIRE FOR COPD SYMPTOMS
YES 28 Centers (96,6%)/29 Centers (100%)
NO 1 Center (3,4%)/0 Centers (0%)
CENTERS AWARE ABOUT THE NHI REPSIRATORY RISK CARDS
YES 26 Centers (89,7%)/28 Centers (96,55%)
NO 3 Centers (10,3%)/1 Center (3,45%)
CENTERS THAT CONSIDER THE NHI RISK CARDS APPLICABLE BY THEIR LOCAL GPs
YES 22 Centers (75,9%)/22 Centers (75,9%)
NO 7 Centers (24,1%)/7 Centers (24,1%)
CENTERS THAT PROVIDE, DIRECTLY OR THROUGH A DEDICATED SERVICE, THEIR COPD SMOKER PATIENTS WITH BEHAVIORAL-
PHARMACOLOGICAL SMOKING CESSATION TREATMENT
YES 21 Centers (72,4%)/21 Centers (72,4%)
NO 8 Centers (27,6%)/8 Centers (27,6%)
METHOD USED BY THE CENTERS FOR PRESCRIBING HOME LONG-TERM OXYGEN THERAPY
PRESCRIPTION BY A SPECIALIST OR CONFIRMED BY A SPECIALIST IF MADE BY A NON PNEUMOLOGIST 20 Centers (69,0%)
OTHER (THE ONLY PRESCRIBING CENTERS IN THE HOSPITAL SYSTEM) 9 Centers (31,0%)
ANYONE CAN PRESCRIBE O2 WITHOUT NEED FOR CONFIRMATION BY A PNEUMOLOGIST 0 Centers (0%)
(N.B. IN THE SECOND PHASE THE RESPONSE OPTIONS WERE DIFFERENT)
PRESCRIPTION BY A SPECIALIST OR SPECIALIST CONFIRMATION NEEDED IF PRESCRIPTION MADE BY A NON
PNEUMOLOGIST PHYSICIAN
20 Centers (69,0%)
ONLY THROUGH PRESCRIPTION BY A SPECIALIST 1 Center (3,44%)
ONLY THROUGH PRESCRIPTION BY A HOSPITAL-BASED PNEUMOLOGIST 1 Center (3,44%)
NO RESPONSE 1 Center (3,44%)
OTHER 6 Centers (20,68%)
CENTERS THAT PERIODICALLY CHECK THE OXYGEN FLOW PRESCRIBED AND IF THERE IS STILL NEED FOR LTOT
YES 27 Centers (93,1%)/27 Centers (93,1%)
NO 2 Centers (6,9%)/2 Centers (6,9%)
CENTERS THAT ARE EQUIPPED TO PROVIDE, DIRECTLY OR BY MEANS OF A DEDICATED SERVICE, PULMONARY REHABILITATION TREATMENT
TO THEIR COPD PATIENTS
YES 13 Centers (44,8%)/17 Centers (58,62%)
NO 16 Centers (55,2%)/12 Centers (41,37%)
CENTERS THAT ARE EQUIPPED TO TREAT, DIRECTLY OR BY MEANS OF A DEDICATED SERVICE, THEIR COPD PATIENTS IN ACUTE RESPIRATORY
FAILURE, THROUGH A:
UNIT OF INTENSIVE INTERMEDIATE RESPIRATORY CARE 5 Centers (17,2%)/7 Centers (24,13%)
FOLLOW UP UNIT 9 Centers (31,8%)/2 Centers (6,89%)
INTENSIVE CARE UNIT 6 Centers (20,7%)/5 Centers (17,24%)
INTENSIVE CARE UNIT + UNIT OF INTENSIVE INTERMEDIATE RESPIRATORY CARE 1 Center (3,4%)/8 Centers (27,58%)
NO RESPONSE 8 Centers (27,6%)/7 Centers (24,13%)
IS YOUR CENTER ABLE TO OFFER PATIENTS A COURSE OF EDUCATION ABOUT THE DISEASE?
YES 13 Centers (44,8%)/14 Centers (48,27%)
NO 16 Centers (55,2%)/15 Centers (51,72%)
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Table 5 Implementation forms (Continued)
CENTERS ORGANIZED TO CONSULT WITH THE GP REGARDING THE PATIENT’S DISCHARGE FROM HOSPITAL
YES 7 (24,1%)/8 Centers (27,58%)
NO 22 (75,9%)/21 Centers (72,41%)
CENTERS EQUIPPED WITH A HOME CARE SERVICE
NO SERVICE AVAILABLE 12 Centers (41,4%)/16 Centers (55,17%)
SAME FOR ALL CHRONIC PATIENTS IN HOME CARE WITH DISTRICT NURSES 17 Centers (58,6%)/12 Centers (41,37%)
SPECIALIZED FOR CHRONIC RESPIRATORY FAILURE PATIENTS 0 Centers (0%)/1 Center (3,44%)
CENTERS EQUIPPED WITH A TELE-ASSISTANCE SERVICE
YES 0 Centers (0%)/0 Centers (0%)
NO 29 Centers (100%)/29 Centers (100%)
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situation regarding smoking cessation shows what the
current weak points are. The guidelines state: “…in this
context, smoking cessation is, on the part of the patient,
categorical” and: “...all smoker patients diagnosed with
COPD, in whom smoking cessation is an essential thera-
peutic measure, must be provided with behavioral and
pharmacological treatment for the cessation of the smo-
king habit…”. Patients in whom smoking status was
recorded (i.e. smoker yes/no?) represented only 36.05%
of the total at the first survey, a result that is clearly in-
adequate. At the second survey this percentage rose to
85%, which was defined as excellent. Recording of the
use of pharmacological and behavioral treatment to quit
smoking resulted at the first assessment to be highly
inadequate (3.44%), and this score – though improved –
remained still inadequate at the second assessment (24%).
Finally, only 21 out of 29 centers (72%) are equipped
to provide COPD smoker patients with behavioral-
pharmacological treatments to quit smoking. As
predictable, this percentage remained unvaried at the
second survey; in other words, although the specialists
tried – with success – to improve their performance,
the context in which they operate – which was also
inadequate – did not change. From these findings one can
conclude that smoking treatment was not made available
to all who needed it and this is attributable both to the
incomplete professional training, and to the insufficient
availability (on the part of the National Health System) of
specialized personnel for smoking cessation.
As regards early diagnosis, this is made possible by
patients’ recognition of their own symptoms – which are
present but often ignored or underestimated by the
patient – as well as by their awareness of belonging to a
high risk class. The situation analyzed through our sam-
ple seems positive given the recorded possibility of using
a questionnaire that focuses the patient’s attention on
their own symptoms (97% and 100%), even if obviously it
is necessary to clarify the “setting” in which such a ques-
tionnaire can be used.The risk cards produced by the NHI, utilizable for the
screening of the general population, are well known (by
almost all, at the second survey), but are held to be not
universally applicable (by 22 centers out of 29, 76%,
which remained unvaried at the second survey). This
seems to be attributable to the fact that while the first
instrument (questionnaire) is filled out by the patient, the
second (risk cards) requires a greater intervention on the
part of the GP, whose time is already heavily burdened.
The appropriateness of therapy, once the diagnosis of
bronchial obstruction has been formulated, refers both
to the functional level and to the symptomatology of the
patient [10,11]. As far as the diagnosis is concerned, 86%
of the sample examined uses the so-called fixed ratio
(FEV1/FVC < 70%) and only 4 out of 29 centers use the
lower limit of normality (LLN). It seems to us that this
result cannot be considered a sign of diagnostic inad-
equacy (and consequent therapeutic inappropriateness)
because, even if there is evidence in the literature dem-
onstrating overestimation of the disease in males and in
elderly persons [17], it is also true that – as underlined
in the AGE.NA.S guidelines [10] - “the current lack of
reliable estimates of the distribution of values of the
FEV1/FVC ratio in the various age-groups renders
impracticable a diagnosis based on values below the
5thcentile of the distribution of FEV1/FVC in the refe-
rence population, considering that the 5thcentile is chosen
conventionally as the lower limit of normal values.”
Moreover, given that spirometry is not carried out on
the whole population but only on those at risk or symp-
tomatic individuals, for whom there is thus a founded
diagnostic suspicion, “the potential diagnostic error due to
the choice of 0.70 as the fixed lower limit of normality of
the ratio FEV1/FVC will be reduced by the extent of
clinical probability of disease before performing the spiro-
metry test” [10]. It is significant that, even after the training
day in which the reasons in favor of the LLN were pre-
sented, the percentage of those who use it did not change.
The percentage of patients with record of at least one
spirometry performed within the previous year passed
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(91.5%) at the second, while the percentage of patients
with reported functional staging passed from 40% to
91.4%. Also other important parameters for the clinical
staging and follow-up saw the percentage pass from
unsatisfactory to good, e.g. BMI (from 33% to 69%),
presence of comorbidities (from 37% to 89%), level of
dyspnea (from 23.4% to 59%). Of note, regarding dys-
pnea, there is no standardization as yet concerning the
type of scale used to measure this symptom and the
heterogeneity of methods used to evaluate dyspnea is
evidently a disadvantage for the appropriateness of sta-
ging and follow-up. The guidelines [10] consider only
the Medical Research Council (MRC) scale, and in fact
in our sample it was at the first assessment the one most
used (alone or in association) and after training it remained
the one most preferred.
The prescription of home oxygen therapy is governed
by the pneumologist in 100% of cases and this places on
pneumologists specific responsibilities that are well
delineated by the guidelines [10,11]. The guidelines rec-
ommend, in fact, besides indicating the precise reference
values of oxygen saturation for the prescription, to verify
over time the efficacy of the chosen oxygen flows and
that there is still an indication for oxygen. In our sample,
the first survey showed an inadequate number of blood
gas analyses reported (23.5%) but we found a consider-
able improvement at the second (53%), even if the per-
centage is still not good. In contrast, a good percentage
was observed at the second survey for reported mea-
surement of oxygen saturation, which passed from 37.3%
at the first survey to 90.4% at the second. Adequate also
was the percentage of centers that are organized to peri-
odically check the suitability of continuing home oxygen
therapy (27 centers out of 29, equal to 93%); of note,
however, in the 6 months between the first and second
survey we did not find any improvement in this latter
parameter.
According to the guideline recommendations [10,11],
patients’ level of severity should be graded not only by
means of spirometry, but also with the use of other mea-
surements besides those of pulse oximetry and blood gas
analysis. Included in these measurements are BMI and
the 6-min walking test: both these parameters saw an
improvement in their recording from the first to second
survey (respectively from 33% to 69% and from 15.5%
to 59.2%).
Information about patients who had been treated for
exacerbation by their own GP or admitted to a different
ward from the outpatient clinic that usually handles
them could not be directly accessed by the outpatient
clinic but could only be gained from interview with the
patient (often with a high level of imprecision). As a
result, such information was found to be inadequate inour sample, not only at the first but also at the second
survey (from 24% to 64% for exacerbation, and from
17.5% to 45% for hospitalization), testifying to the ob-
jective difficulty experienced with gathering this infor-
mation. Given the importance that such information has
for the grading of severity, and thus for determining
appropriateness of the treatment, it is evident that the
context in which the specialist operates will be in-
adequate until this information is available through an
online network.
Reporting the prescribed long-term respiratory therapy
is important for the follow-up of the patient. This report,
which initially was barely adequate (40% of the sample),
improved markedly at the second assessment (86%). At
both surveys we observed a predictable heterogeneity of
the type of pharmaceutical drugs used by the Centers. It
was not the scope of this audit to evaluate the appropri-
ateness of drug prescription of individual patients in
relation to their level of severity; analyzing sensitive data
of such a nature in an observational study needs in fact
to be approved by the Ethics Committee of the respec-
tive Centers. However, we did observe after the training
course an increased number of Centers utilizing long-
acting bronchodilators (LABA or Ultra LABA or LAMA)
alone or in combination with each other or together with
inhaled corticosteroids (ICS), with a mean increase of
20.6% (C.I.: from +6.9 to +34.5). This finding, though
merely a rough indication, combined with the significant
increase seen in the reporting of long-term respiratory
therapy, confirms the importance of training as a means to
improve specialist appropriateness.
Finally, given that pulmonary rehabilitation (PR) is
considered to be necessary at all stages of disease seve-
rity [10], the reported need for PR, which is only 23.1%
of patients, and passed to 25.55% at the second survey,
probably reflects a lack of offer, apparently confirmed by
the low percentage of Centers that are able to offer
patients a programm of pulmonary rehabilitation (45%
which rose to 59% at the second assessment).
The inadequacy of the organizational context emerges
strongly as regards the availability of tele-care and
“specialist” home care, both of which are completely or
almost completely unavailable (0% and 1%). Moreover, at
the second survey there was an increase in the number of
Centers completely unable to provide home care: the rea-
son for this is unknown, but one presumes it is due to
the need to reduce management costs: if this is true, it
would be yet another demonstration of the inadequacy of
the organizational context.
A more complex reflection is required in analyzing the
responses regarding the treatment of patients in a state
of acute respiratory failure. As can be seen from a com-
parison between the first and second assessment, after
the discussion that ensued on the data collected in the
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active in the Centers were classified. Considering that no
variation in the organization models occurred during the
interval, the variation in the responses (that shifted
towards a classification as internal and autonomous ICUs
or sub-intensive units) should be interpreted as a greater
awareness of the need to change the care models to bring
them more into line with the real care needs of patients
in a state of respiratory failure. As a matter of fact, know-
ing well both the single realities and the national context,
there is no case in which an autonomous Unit exists as a
structural organization, but the experiences are limited
to management with ventilation in the mixed diagnostic-
therapeutic reality of a Pulmonary ward.
Acute and/or acute-on-chronic respiratory diseases
represent now an increasingly significant epidemiological
fact, and it is indispensable that modern Pulmonary Units
be equipped with beds that are reserved and adequate to
receive patients in critical respiratory conditions. This
would also avoid depleting the resources (instrumental
and economic) of the ICUs, whose burden of patients –
both incoming and outgoing - would as a result be consi-
derably lightened. The treatment of severe respiratory
failure includes as a distinctive element the use (besides
pharmacological treatment) of non-invasive mechanical
ventilation (NIV), assuring the patient at the same time a
continuous instrumental monitoring of the vital parame-
ters. In this sense, NIV is now in all guidelines, including
the official Italian documents [10,11], established as a key
part of the treatment of respiratory failure, and its absence
constitutes a serious omission of care, which is increasingly
debated in legal medicine in terms of ignorance, inability,
or incapacity.
Finally, to ensure management appropriateness it is
well known that the indispensable elements are: self-
management, care continuity and the presence of
diverse figures (not only the GP and/or specialists,
but also the pharmacist and family caregivers). Con-
cerning the possibility of educating patients about the
disease and its management (“empowerment”) only 13
(which passed to 14 at the second assessment) out of
29 Centers offer this service. The procedure of jointly
consulting with the GP before discharging patients
(first and indispensable step for “care continuity”) is
implemented in only 7 (8 at the second assessment) out
of 29 Centers.
Conclusions
At the first survey carried out, only one in three Centers
on average recorded the information requested by the
guidelines [10,11], and for some items even less than 1
in 6 centers recorded the information requested. Many
of these percentages, however, improved substantially
after the training session carried out in May 2012. Itcould be argued that all this effort is scarcely worthwhile,
given that the lack of recording does not necessarily imply
a lack of measurement and that, in fact, many – if not
almost all – the parameters considered were certainly
assessed as they are indispensable for formulating the diag-
nosis (e.g. spirometry), for staging and for the therapeutic
prescription (e.g. for the prescription of oxygen therapy). It
is however true that other information, whose collection is
less routine in outpatient clinical practice, such as BMI,
presence of comorbidities, and number of admissions for
exacerbations in the preceding year, may effectively not
have been “assessed”.
In any case, the lack of recording means that the
patient information is not immediately available to
others or “independent”, i.e. it is not “unlinked” from the
professional in whose care the patient is, with the risk of
perpetuating the model of episodic consultation that is
not part of an organized system. Moreover the lack of
availability of essential data impedes also an evaluation
(internal and external) of the “appropriateness” of the steps
carried out.
The Implementation forms related to the context in
which the specialist operates showed far more serious
gaps: in the field of smoking cessation treatment, in that
of pulmonary rehabilitation, of patient education about
the disease, of the continuity of care, home care and
tele-care.
Our findings highlight some important points: com-
pared to the standard represented by the guideline
recommendations, both individual specialist practice and
the organizational context show significant gaps. If what
is in line with the recommendations can be defined as
‘appropriate’ and what is not in line as ‘inappropriate’,
then a significant degree of inappropriateness exists. From
the data gathered from our sample, it seems that with
training and collective/individual effort the inappropriate-
ness present in specialist practice can be resolved – and
quite rapidly – but the gaps present in the organizational
context (logistic-management structures) require more
time to be resolved as well as a commitment on the part of
other stakeholders.
Thus the question of “appropriateness” cannot be
reduced to a matter concerning just the health profes-
sional or be resolved “on paper” as a matter of pharma-
cological therapy alone. We believe that the solution to
the areas of inappropriateness highlighted depends on
diverse subjects. Health professionals are certainly
responsible for inappropriateness stemming from their
lack of up-to-date knowledge, but Scientific Societies are
responsible for the lack of standardization of instruments
for clinical-functional data collection, and the National
Health Service for the absence (or inadequacy) of the logis-
tic structures required for the integrated management of
chronic respiratory disease.
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targeted training and with individual effort, specialist
behavior can be modified and brought into line with
what is recommended by the institutional guidelines
[10,11] but it also shows that correcting the inappro-
priateness of the specialist is not sufficient to make the
care for chronic respiratory diseases “appropriate”; for this,
modification of inappropriateness “of the system” is
required on the part of the NHS.
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